Status and phase
Conditions
Treatments
About
This study aim is to observe the response to Bambuterol Hydrochloride tablets treatment in subjects with eosinophilic bronchitis .
The investigators hypothesize:
A few of subjects with EB have some responses to Bambuterol Hydrochloride tablets therapy.
Most of subjects with CVA respond well to Bambuterol Hydrochloride tablets therapy
Full description
Study groups:
45 patients with chronic cough will be collected and two groups will formed based on diagnosis as follows:
Group 1: EB group The patients with eosinophilic bronchitis received Bambuterol Hydrochloride tablets 10mg Q24 for three days .
Group 2: CVA group The patients with cough variant asthma received Bambuterol Hydrochloride tablets 10mg Q24 for three days .
Observe the response to Bambuterol Hydrochloride tablets treatment three days later and compare the effective rate of patients with EB and CVA. Then the study will be over.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
45 participants in 2 patient groups
Loading...
Central trial contact
Lai Kefang, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal